Asked by: Luciana Berger (Liberal Democrat - Liverpool, Wavertree)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of trends in the level of the Public Health Grant in (a) the current Spending Review Period and (b) the next Spending Review on the (i) level of quality of drug treatment services and (ii) number of drug-related deaths.
Answered by Seema Kennedy
The Government is concerned by the number of drug-related deaths, which is largely caused by an ageing cohort of heroin users. We are supporting local areas to develop a more joined up approach to commissioning and delivering the range of services that are essential to supporting recovery and preventing drug-related deaths. In October, the Home Office announced that there would be a major independent review of drug misuse. This will look at a wide range of issues, including the system of support and enforcement around drug abuse, to better inform our thinking about what more can be done to tackle drug harms including deaths. The review will inform our thinking about what more can be done to mitigate the harm caused through drug use.
Local authorities will receive £3.1 billion in 2019/20, ring-fenced exclusively for use on public health, including drug addiction. We are investing over £16 billion in local authority public health services over the five years of the 2015 Spending Review until 2020/21. Public health funding for 2020 onwards, including for addiction services, will be considered carefully in the next Spending Review, in the light of the available evidence.
Asked by: Luciana Berger (Liberal Democrat - Liverpool, Wavertree)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many and what proportion of care homes are rated inadequate by the Care Quality Commission in (a) Liverpool, (b) the North West and (c) England.
Answered by Caroline Dinenage
The Care Quality Commission (CQC) has provided the following data:
- | Number of active care homes with latest overall rating as ‘Inadequate’ | Total active care homes | Percentage1 of active care homes by latest overall rating |
Liverpool Local Authority | 1 | 89 | 1.1% |
North West Region | 20 | 1,915 | 1.0% |
England | 230 | 15,668 | 1.5% |
Notes: 1Percentages for each latest overall rating are as a proportion of total active care homes, including homes with no published rating to date.
The data provided can be used in accordance with the Open Government Licence for Public Sector Information by acknowledging the CQC as the data source.
Asked by: Luciana Berger (Liberal Democrat - Liverpool, Wavertree)
Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, what estimate his Department has made of the amount UK Research and Innovation has spent on research into (a) physical health conditions and (b) mental health conditions in each of the last 5 years.
Answered by Chris Skidmore
We are increasing spending on R&D by £7 billion over 5 years by 2021-22. This will be the largest increase ever.
UK Research and Innovation (UKRI), a partner organisation of BEIS, funds research relating to health. Funding decisions are based on the quality of the proposals, with researcher-led proposals welcomed into any aspect of human health, with the primary considerations being research excellence and importance to health.
Within UKRI, the Medical Research Council (MRC) is the primary, but not exclusive, funder of medical research. Over the last five years, MRC has provided the following health funding:
MRC Health Research (HRCS) | 2013/14 (£) | 2014/15 (£) | 2015/16 (£) | 2016/17 (£) | 2017/18 (£) |
All Health Categories | 617,605,780 | 625,128,039 | 723,428,975 | 599,790,930 | 585,079,573 |
Of which Mental Health | 30,240,645 | 31,222,399 | 30,585,328 | 28,557,922 | 39,879,007 |
Of which Neurological | 79,901,444 | 79,832,753 | 109,809,894 | 80,286,626 | 74,631,328 |
All Prevention Research | 26,587,238 | 24,479,417 | 22,348,094 | 24,157,949 | 30,297,781 |
Of which Mental Health | 815,707 | 587,725 | 453,152 | 391,856 | 415,533 |
Of which Neurological | 17,006 | 22,812 | 25,047 | 33,037 | 36,383 |
Please note this does not represent the MRC’s entire research spend as some investments, such as infrastructure and underpinning research are not included in the analysis.
Research relating to mental health is funded by all UKRI councils. As well as UKRI, other government bodies fund health research, such as the National Institute for Health Research (NIHR). The UK Clinical Research Collaboration undertakes UK Health Research Analysis. An analysis of data for 2018 is expected to the published in summer 2019. The most recent report (in 2014) included data from seven of UKRI’s nine councils as well as other government departments and charitable organisations. The report and data are available at https://hrcsonline.net/reports/analysis-reports/
Further related initiatives include:
On 5 December 2018, the government announced up to £79 million of Industrial Strategy funding for a new programme of research that will harness the power of artificial intelligence and big data to dramatically change the way major diseases are detected, diagnosed and treated. The funding, which forms part of the government’s Life Sciences Sector Deal 2, will support the establishment of a landmark cohort of up to five million people to take part in research aimed at revolutionising early detection and diagnosis of a range of diseases, including Alzheimer’s and other dementias. The programme will bring together the NHS, industry and leading charities including Alzheimer’s Research UK, Cancer Research UK and the British Heart Foundation.
Asked by: Luciana Berger (Liberal Democrat - Liverpool, Wavertree)
Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, whether UK Research and Innovation has plans to increase the proportion of funding allocated to research into mental illness in the next financial year.
Answered by Chris Skidmore
We are increasing spending on R&D by £7 billion over 5 years by 2021-22. This will be the largest increase ever.
UK Research and Innovation (UKRI), a partner organisation of BEIS, funds research relating to health. Funding decisions are based on the quality of the proposals, with researcher-led proposals welcomed into any aspect of human health, with the primary considerations being research excellence and importance to health.
Within UKRI, the Medical Research Council (MRC) is the primary, but not exclusive, funder of medical research. Over the last five years, MRC has provided the following health funding:
MRC Health Research (HRCS) | 2013/14 (£) | 2014/15 (£) | 2015/16 (£) | 2016/17 (£) | 2017/18 (£) |
All Health Categories | 617,605,780 | 625,128,039 | 723,428,975 | 599,790,930 | 585,079,573 |
Of which Mental Health | 30,240,645 | 31,222,399 | 30,585,328 | 28,557,922 | 39,879,007 |
Of which Neurological | 79,901,444 | 79,832,753 | 109,809,894 | 80,286,626 | 74,631,328 |
All Prevention Research | 26,587,238 | 24,479,417 | 22,348,094 | 24,157,949 | 30,297,781 |
Of which Mental Health | 815,707 | 587,725 | 453,152 | 391,856 | 415,533 |
Of which Neurological | 17,006 | 22,812 | 25,047 | 33,037 | 36,383 |
Please note this does not represent the MRC’s entire research spend as some investments, such as infrastructure and underpinning research are not included in the analysis.
Research relating to mental health is funded by all UKRI councils. As well as UKRI, other government bodies fund health research, such as the National Institute for Health Research (NIHR). The UK Clinical Research Collaboration undertakes UK Health Research Analysis. An analysis of data for 2018 is expected to the published in summer 2019. The most recent report (in 2014) included data from seven of UKRI’s nine councils as well as other government departments and charitable organisations. The report and data are available at https://hrcsonline.net/reports/analysis-reports/
Further related initiatives include:
On 5 December 2018, the government announced up to £79 million of Industrial Strategy funding for a new programme of research that will harness the power of artificial intelligence and big data to dramatically change the way major diseases are detected, diagnosed and treated. The funding, which forms part of the government’s Life Sciences Sector Deal 2, will support the establishment of a landmark cohort of up to five million people to take part in research aimed at revolutionising early detection and diagnosis of a range of diseases, including Alzheimer’s and other dementias. The programme will bring together the NHS, industry and leading charities including Alzheimer’s Research UK, Cancer Research UK and the British Heart Foundation.
Asked by: Luciana Berger (Liberal Democrat - Liverpool, Wavertree)
Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, how UK Research and Innovation considers the disease burden of individual conditions when commissioning funding for individual health research projects.
Answered by Chris Skidmore
We are increasing spending on R&D by £7 billion over 5 years by 2021-22. This will be the largest increase ever.
UK Research and Innovation (UKRI), a partner organisation of BEIS, funds research relating to health. Funding decisions are based on the quality of the proposals, with researcher-led proposals welcomed into any aspect of human health, with the primary considerations being research excellence and importance to health.
Within UKRI, the Medical Research Council (MRC) is the primary, but not exclusive, funder of medical research. Over the last five years, MRC has provided the following health funding:
MRC Health Research (HRCS) | 2013/14 (£) | 2014/15 (£) | 2015/16 (£) | 2016/17 (£) | 2017/18 (£) |
All Health Categories | 617,605,780 | 625,128,039 | 723,428,975 | 599,790,930 | 585,079,573 |
Of which Mental Health | 30,240,645 | 31,222,399 | 30,585,328 | 28,557,922 | 39,879,007 |
Of which Neurological | 79,901,444 | 79,832,753 | 109,809,894 | 80,286,626 | 74,631,328 |
All Prevention Research | 26,587,238 | 24,479,417 | 22,348,094 | 24,157,949 | 30,297,781 |
Of which Mental Health | 815,707 | 587,725 | 453,152 | 391,856 | 415,533 |
Of which Neurological | 17,006 | 22,812 | 25,047 | 33,037 | 36,383 |
Please note this does not represent the MRC’s entire research spend as some investments, such as infrastructure and underpinning research are not included in the analysis.
Research relating to mental health is funded by all UKRI councils. As well as UKRI, other government bodies fund health research, such as the National Institute for Health Research (NIHR). The UK Clinical Research Collaboration undertakes UK Health Research Analysis. An analysis of data for 2018 is expected to the published in summer 2019. The most recent report (in 2014) included data from seven of UKRI’s nine councils as well as other government departments and charitable organisations. The report and data are available at https://hrcsonline.net/reports/analysis-reports/
Further related initiatives include:
On 5 December 2018, the government announced up to £79 million of Industrial Strategy funding for a new programme of research that will harness the power of artificial intelligence and big data to dramatically change the way major diseases are detected, diagnosed and treated. The funding, which forms part of the government’s Life Sciences Sector Deal 2, will support the establishment of a landmark cohort of up to five million people to take part in research aimed at revolutionising early detection and diagnosis of a range of diseases, including Alzheimer’s and other dementias. The programme will bring together the NHS, industry and leading charities including Alzheimer’s Research UK, Cancer Research UK and the British Heart Foundation.
Asked by: Luciana Berger (Liberal Democrat - Liverpool, Wavertree)
Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, what estimate he has made of the cost to UK Research and Innovation of research on the prevention of (a) mental and (b) physical ill health in each of the last five years.
Answered by Chris Skidmore
We are increasing spending on R&D by £7 billion over 5 years by 2021-22. This will be the largest increase ever.
UK Research and Innovation (UKRI), a partner organisation of BEIS, funds research relating to health. Funding decisions are based on the quality of the proposals, with researcher-led proposals welcomed into any aspect of human health, with the primary considerations being research excellence and importance to health.
Within UKRI, the Medical Research Council (MRC) is the primary, but not exclusive, funder of medical research. Over the last five years, MRC has provided the following health funding:
MRC Health Research (HRCS) | 2013/14 (£) | 2014/15 (£) | 2015/16 (£) | 2016/17 (£) | 2017/18 (£) |
All Health Categories | 617,605,780 | 625,128,039 | 723,428,975 | 599,790,930 | 585,079,573 |
Of which Mental Health | 30,240,645 | 31,222,399 | 30,585,328 | 28,557,922 | 39,879,007 |
Of which Neurological | 79,901,444 | 79,832,753 | 109,809,894 | 80,286,626 | 74,631,328 |
All Prevention Research | 26,587,238 | 24,479,417 | 22,348,094 | 24,157,949 | 30,297,781 |
Of which Mental Health | 815,707 | 587,725 | 453,152 | 391,856 | 415,533 |
Of which Neurological | 17,006 | 22,812 | 25,047 | 33,037 | 36,383 |
Please note this does not represent the MRC’s entire research spend as some investments, such as infrastructure and underpinning research are not included in the analysis.
Research relating to mental health is funded by all UKRI councils. As well as UKRI, other government bodies fund health research, such as the National Institute for Health Research (NIHR). The UK Clinical Research Collaboration undertakes UK Health Research Analysis. An analysis of data for 2018 is expected to the published in summer 2019. The most recent report (in 2014) included data from seven of UKRI’s nine councils as well as other government departments and charitable organisations. The report and data are available at https://hrcsonline.net/reports/analysis-reports/
Further related initiatives include:
On 5 December 2018, the government announced up to £79 million of Industrial Strategy funding for a new programme of research that will harness the power of artificial intelligence and big data to dramatically change the way major diseases are detected, diagnosed and treated. The funding, which forms part of the government’s Life Sciences Sector Deal 2, will support the establishment of a landmark cohort of up to five million people to take part in research aimed at revolutionising early detection and diagnosis of a range of diseases, including Alzheimer’s and other dementias. The programme will bring together the NHS, industry and leading charities including Alzheimer’s Research UK, Cancer Research UK and the British Heart Foundation.
Asked by: Luciana Berger (Liberal Democrat - Liverpool, Wavertree)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the oral statement of 5 November 2018, Official Report, column 1269, what progress he has made on the structure of a health in all policies approach to policy-making.
Answered by Seema Kennedy
In the Prevention Vision document, ‘Prevention is Better Than Cure’, we committed to publishing a Prevention Green Paper setting out Government plans on prevention in more detail, including our approach to health in all policies. This Green Paper will be published in due course.
Asked by: Luciana Berger (Liberal Democrat - Liverpool, Wavertree)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 May 2019 to Question 254804, when the National Suicide Prevention Strategy will be published.
Answered by Jackie Doyle-Price
The National Suicide Prevention Strategy was first published in 2012 as the cross-Government outcomes strategy, ‘Preventing Suicide in England’.
We have published a number of progress reports since then with the third progress report, published in January 2017, updating the 2012 strategy in a number of areas. The latest progress report was published in January 2019 together with a cross-Government suicide prevention workplan which sets out an ambitious programme across central and local government and delivery agencies to reduce suicide. These documents are available at the following link:
www.gov.uk/government/collections/suicide-prevention-resources-and-guidance
Asked by: Luciana Berger (Liberal Democrat - Liverpool, Wavertree)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the data published by the Nursing and Midwifery Council on 20 May 2019, what steps his Department is taking to retain nurses that are EU nationals in the NHS.
Answered by Stephen Hammond
The Department is clear that all staff that are European Union nationals are valued and should be made to feel welcome in the United Kingdom and working in the National Health Service. To this end the Department has supported employers in promoting the EU Settlement Scheme and piloting the scheme from December 2018 to NHS and social care employees, before it was launched to the wider public in March 2019.
It should be noted that the rate of European Economic Area citizens leaving the Nursing and Midwifery Council register decreased by 18.1% between April 2018 and March 2019.
Asked by: Luciana Berger (Liberal Democrat - Liverpool, Wavertree)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the interim report published by the Care Quality Commission, published on 20 May 2019, whether he will convene an expert group to consider the delivery of best care to people with learning disabilities and autism.
Answered by Caroline Dinenage
On 21 May 2019, the Care Quality Commission (CQC) published its ‘Interim Report: Review of restraint, prolonged seclusion and segregation for people with a mental health problem, a learning disability and or autism.’ The Government has accepted all five of the recommendations in the CQC’s interim report including the recommendation that an expert group, that includes clinicians, people with lived experience and academics, should be convened to consider what would be the key features of a better system of care for this specific group of people (that is those with a learning disability and/or autism whose behaviour is so challenging that they are, or are at risk of, being cared for in segregation).
The target in the NHS Long Term Plan is to reduce the number of children with a learning disability, autism or both in a specialist inpatient unit to a level equivalent to no more than 12 to 15 children per one million children in England by 2023-24.